Ramon E. Parsons
Discovered the tumour-suppressor gene PTEN, one of the most frequently lost genes in cancer.
Identified PTEN in 1997 and has since defined its roles in PI3K signalling and cancer predisposition; directs Mount Sinai's cancer institute.
| Title | Journal | Year |
|---|---|---|
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Science | 1997 |
Pages like this
not linked directly; found by shared links- ProductGedatolisib
Shares AKT, PIK3CA / PI3K-alpha, PI3K / AKT / mTOR, HR-positive / HER2-negative breast cancer.
- TrialCAPItello-281
Shares AKT, PI3K / AKT / mTOR, Prostate cancer.
- TrialCAPItello-291
Shares AKT, PIK3CA / PI3K-alpha, HR-positive / HER2-negative breast cancer.
- PairingPI3K/AKT-pathway inhibitor + endocrine therapy (± CDK4/6)
Shares AKT, PIK3CA / PI3K-alpha, PI3K / AKT / mTOR, HR-positive / HER2-negative breast cancer.
- PathwaymRNA translation (eIF4F / mTOR)
Shares AKT, PIK3CA / PI3K-alpha, PI3K / AKT / mTOR.
- ProductInavolisib
Shares PIK3CA / PI3K-alpha, PI3K / AKT / mTOR, HR-positive / HER2-negative breast cancer.
- ProductUmbralisib
Shares PIK3CA / PI3K-alpha, PI3K / AKT / mTOR.
- ProductDuvelisib
Shares PIK3CA / PI3K-alpha, PI3K / AKT / mTOR.